scymnol has been researched along with Kidney Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, SD; Hoivik, J; Macrides, T; Manautou, JE; Naylor, L; Slitt, AL | 1 |
1 other study(ies) available for scymnol and Kidney Diseases
| Article | Year |
|---|---|
The shark bile salt 5 beta-scymnol abates acetaminophen toxicity, but not covalent binding.
Topics: Acetaminophen; Animals; Antioxidants; Bile Acids and Salts; Chemical and Drug Induced Liver Injury; Cholestanols; Glutathione; Indicators and Reagents; Kidney Diseases; L-Lactate Dehydrogenase; Male; Mice; Sharks; Succinate Dehydrogenase | 2004 |